Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Infect Immun ; 87(8)2019 08.
Article in English | MEDLINE | ID: mdl-31109950

ABSTRACT

The Gram-negative intracellular pathogen Burkholderia pseudomallei is the causative agent of melioidosis, an important cause of sepsis in Southeast Asia. Recognition of pathogen-associated molecular patterns by Toll-like receptors (TLRs) is essential for an appropriate immune response during pathogen invasion. In patients with melioidosis, TLR5 is the most abundantly expressed TLR, and a hypofunctional TLR5 variant has been associated with improved survival. Here, we studied the functional role of TLR5 and its ligand flagellin in experimental melioidosis. First, we observed differential TLR5 expression in the pulmonary and hepatic compartments upon infection with B. pseudomallei Next, we found that B. pseudomallei-challenged TLR5-deficient (Tlr5-/- ) mice were more susceptible to infection than wild-type (WT) mice, as demonstrated by higher systemic bacterial loads, increased organ injury, and impaired survival. Lung bacterial loads were not different between the two groups. The phenotype was flagellin independent; no difference in in vivo virulence was observed for the flagellin-lacking mutant MM36 compared to the wild-type B. pseudomallei strain 1026b. Tlr5-/- mice showed a similar impaired antibacterial defense when infected with MM36 or 1026b. Ex vivo experiments showed that TLR5-deficient macrophages display markedly impaired phagocytosis of B. pseudomallei In conclusion, these data suggest that TLR5 deficiency has a detrimental flagellin-independent effect on the host response against pulmonary B. pseudomallei infection.


Subject(s)
Melioidosis/etiology , Toll-Like Receptor 5/physiology , Animals , Burkholderia pseudomallei/physiology , Female , Flagellin/metabolism , Humans , Lung/pathology , Macrophages/physiology , Male , Mice , Mice, Inbred C57BL , Neutrophils/physiology
2.
Eur J Immunol ; 48(1): 66-79, 2018 01.
Article in English | MEDLINE | ID: mdl-28971472

ABSTRACT

Streptococcus (S.) pneumoniae is the most common cause of community-acquired pneumonia. The Nod-like receptor family pyrin domain containing 3 (NLRP3) inflammasome, consisting of NLRP3, ASC (the adaptor apoptosis-associated speck-like protein containing a CARD) and caspase-1, has been implicated in protective immunity during pneumonia induced by high doses of S. pneumoniae serotype 2. Here we investigated the role of the NLRP3 inflammasome in the host response during lethal airway infection with a low dose of serotype 3 S. pneumoniae. Mice were euthanized at predefined endpoints for analysis or observed in survival studies. In additional studies, Tlr2-/- /Tlr4-/- mice and Myd88-/- mice incapable of Toll-like receptor signaling were studied. In stark contrast with existing literature, both Nlrp3-/- and Asc-/- mice showed a strongly improved host defense, as reflected by a markedly reduced mortality rate accompanied by diminished bacterial growth and dissemination. Host defense was unaltered in Tlr2-/- /Tlr4-/- mice and Myd88-/- mice. These results show that the NLRP3 inflammasome impairs host defense during lethal pneumonia caused by serotype 3 S. pneumoniae. Our findings challenge the current paradigm that proximal innate detection systems are indispensable for an adequate host immune response against bacteria.


Subject(s)
CARD Signaling Adaptor Proteins/immunology , NLR Family, Pyrin Domain-Containing 3 Protein/immunology , Pneumonia, Pneumococcal/immunology , Streptococcus pneumoniae/immunology , Animals , CARD Signaling Adaptor Proteins/genetics , Caspase 1/immunology , Community-Acquired Infections/immunology , Community-Acquired Infections/microbiology , Immunity, Innate/genetics , Immunity, Innate/immunology , Mice , Mice, Inbred C57BL , Mice, Knockout , Myeloid Differentiation Factor 88/genetics , NLR Family, Pyrin Domain-Containing 3 Protein/genetics , Pneumonia, Pneumococcal/pathology , Signal Transduction/immunology , Streptococcus pneumoniae/classification , Toll-Like Receptor 2/genetics , Toll-Like Receptor 4/genetics
3.
Am J Physiol Lung Cell Mol Physiol ; 311(2): L219-28, 2016 08 01.
Article in English | MEDLINE | ID: mdl-27288486

ABSTRACT

Pseudomonas aeruginosa is a flagellated pathogen frequently causing pneumonia in hospitalized patients and sufferers of chronic lung disease. Here we investigated the role of the common Toll-like receptor (TLR) adaptor myeloid differentiation factor (MyD)88 in myeloid vs. lung epithelial cells in clearance of P. aeruginosa from the airways. Mice deficient for MyD88 in lung epithelial cells (Sftpccre-MyD88-lox mice) or myeloid cells (LysMcre-MyD88-lox mice) and bone marrow chimeric mice deficient for TLR5 (the receptor recognizing Pseudomonas flagellin) in either parenchymal or hematopoietic cells were infected with P. aeruginosa via the airways. Sftpccre-MyD88-lox mice demonstrated a reduced influx of neutrophils into the bronchoalveolar space and an impaired early antibacterial defense after infection with P. aeruginosa, whereas the response of LysMcre-MyD88-lox mice did not differ from control mice. The immune-enhancing role of epithelial MyD88 was dependent on recognition of pathogen-derived flagellin by epithelial TLR5, as demonstrated by an unaltered clearance of mutant P. aeruginosa lacking flagellin from the lungs of Sftpccre-MyD88-lox mice and an impaired bacterial clearance in bone marrow chimeric mice lacking TLR5 in parenchymal cells. These data indicate that early clearance of P. aeruginosa from the airways is dependent on flagellin-TLR5-MyD88-dependent signaling in respiratory epithelial cells.


Subject(s)
Alveolar Epithelial Cells/immunology , Myeloid Differentiation Factor 88/metabolism , Pneumonia, Bacterial/metabolism , Pseudomonas Infections/metabolism , Pseudomonas aeruginosa/immunology , Alveolar Epithelial Cells/metabolism , Alveolar Epithelial Cells/microbiology , Animals , Flagellin/immunology , Immunity, Innate , Mice, Inbred C57BL , Myeloid Differentiation Factor 88/genetics , Neutrophil Infiltration , Pneumonia, Bacterial/immunology , Pneumonia, Bacterial/microbiology , Pseudomonas Infections/immunology , Pseudomonas Infections/microbiology , Signal Transduction , Toll-Like Receptor 5/metabolism
4.
J Pathol ; 238(1): 74-84, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26365983

ABSTRACT

Klebsiella pneumoniae is among the most common Gram-negative bacteria that cause pneumonia. Gp96 is an endoplasmic reticulum chaperone that is essential for the trafficking and function of Toll-like receptors (TLRs) and integrins. To determine the role of gp96 in myeloid cells in host defence during Klebsiella pneumonia, mice homozygous for the conditional Hsp90b1 allele encoding gp96 were crossed with mice expressing Cre-recombinase under control of the LysM promoter to generate LysMcre-Hsp90b1-flox mice. LysMcre-Hsp90b1-flox mice showed absence of gp96 protein in macrophages and partial depletion in monocytes and granulocytes. This was accompanied by almost complete absence of TLR2 and TLR4 on macrophages. Likewise, integrin subunits CD11b and CD18 were not detectable on macrophages, while being only slightly reduced on monocytes and granulocytes. Gp96-deficient macrophages did not release pro-inflammatory cytokines in response to Klebsiella and displayed reduced phagocytic capacity independent of CD18. LysMcre-Hsp90b1-flox mice were highly vulnerable to lower airway infection induced by K. pneumoniae, as reflected by enhanced bacterial growth and a higher mortality rate. The early inflammatory response in Hsp90b1-flox mice was characterized by strongly impaired recruitment of granulocytes into the lungs, accompanied by attenuated production of pro-inflammatory cytokines, while the inflammatory response during late-stage pneumonia was not dependent on the presence of gp96. Blocking CD18 did not reproduce the impaired host defence of LysMcre-Hsp90b1-flox mice during Klebsiella pneumonia. These data indicate that macrophage gp96 is essential for protective immunity during Gram-negative pneumonia by regulating TLR expression.


Subject(s)
Klebsiella Infections/immunology , Membrane Glycoproteins/immunology , Pneumonia, Bacterial/immunology , Animals , Blotting, Western , Disease Models, Animal , Endoplasmic Reticulum/immunology , Endoplasmic Reticulum/metabolism , Flow Cytometry , Klebsiella pneumoniae , Macrophages/immunology , Mice , Mice, Inbred C57BL , Mice, Transgenic , Molecular Chaperones/immunology , Polymerase Chain Reaction
5.
J Innate Immun ; 7(6): 637-46, 2015.
Article in English | MEDLINE | ID: mdl-26065469

ABSTRACT

Klebsiella pneumoniae is an important cause of Gram-negative pneumonia and sepsis. Mice deficient for TIR-domain-containing adaptor-inducing interferon-ß (TRIF) demonstrate enhanced bacterial growth and dissemination during Klebsiella pneumonia. We show here that the impaired antibacterial defense of TRIF mutant mice is associated with absent interferon (IFN)-x03B3; production in the lungs. IFN-x03B3; production by splenocytes in response to K. pneumoniae in vitro was critically dependent on Toll-like receptor 4 (TLR4), the common TLR adaptor myeloid differentiation primary response gene (MyD88) and TRIF. Reconstitution of TRIF mutant mice with recombinant IFN-x03B3; via the airways reduced bacterial loads in lungs and distant body sites to levels measured in wild-type mice, and partially restored pulmonary cytokine levels. The IFN-x03B3;-induced, improved, enhanced antibacterial response in TRIF mutant mice occurred at the expense of increased hepatocellular injury. These data indicate that TRIF mediates antibacterial defense during Gram-negative pneumonia, at least in part, by inducing IFN-x03B3; at the primary site of infection.


Subject(s)
Adaptor Proteins, Vesicular Transport/immunology , Interferon-gamma/immunology , Klebsiella Infections/immunology , Klebsiella pneumoniae/immunology , Pneumonia, Bacterial/immunology , Adaptor Proteins, Vesicular Transport/genetics , Animals , Interferon-gamma/genetics , Klebsiella Infections/genetics , Klebsiella Infections/pathology , Mice , Mice, Knockout , Pneumonia, Bacterial/genetics , Pneumonia, Bacterial/pathology
6.
PLoS Pathog ; 10(9): e1004368, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25254554

ABSTRACT

Klebsiella pneumoniae is an important cause of sepsis. The common Toll-like receptor adapter myeloid differentiation primary response gene (MyD)88 is crucial for host defense against Klebsiella. Here we investigated the role of MyD88 in myeloid and endothelial cells during Klebsiella pneumosepsis. Mice deficient for MyD88 in myeloid (LysM-Myd88(-/-)) and myeloid plus endothelial (Tie2-Myd88(-/-)) cells showed enhanced lethality and bacterial growth. Tie2-Myd88(-/-) mice reconstituted with control bone marrow, representing mice with a selective MyD88 deficiency in endothelial cells, showed an unremarkable antibacterial defense. Myeloid or endothelial cell MyD88 deficiency did not impact on lung pathology or distant organ injury during late stage sepsis, while LysM-Myd88(-/-) mice demonstrated a strongly attenuated inflammatory response in the airways early after infection. These data suggest that myeloid but not endothelial MyD88 is important for host defense during gram-negative pneumonia derived sepsis.


Subject(s)
Endothelium, Vascular/pathology , Immunity, Innate/immunology , Klebsiella Infections/immunology , Myeloid Cells/pathology , Myeloid Differentiation Factor 88/physiology , Pneumonia, Bacterial/immunology , Sepsis/etiology , Animals , Blotting, Western , Bone Marrow Transplantation , Cells, Cultured , Cytokines/immunology , Cytokines/metabolism , Endothelium, Vascular/immunology , Female , Host-Pathogen Interactions , Inflammation/etiology , Inflammation/pathology , Klebsiella Infections/microbiology , Klebsiella pneumoniae , Lung/immunology , Lung/pathology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Myeloid Cells/immunology , RNA, Messenger/genetics , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction
7.
BMC Immunol ; 15: 30, 2014 Aug 13.
Article in English | MEDLINE | ID: mdl-25115174

ABSTRACT

BACKGROUND: The inflammasome is an intracellular protein complex triggered by exposure to intracellular pathogens, its components or other endogenous proteins. It leads to the activation of and subsequent release of proinflammatory cytokines such as IL-1ß and IL-18. S. Typhimurium is a Gram-negative intracellular bacterium, which is known to trigger inflammasome assembly via recognition by the cytosolic receptors, NLRP3 and NLRC4 (which act via the adaptor protein, ASC) to induce cell death and cytokine release. We sought to characterize the role of ASC and NLRP3 in two different murine models (typhoid and colitis) of systemic Salmonella infection. RESULTS: Release of the inflammasome cytokine IL-18 was hampered in Asc-/- but not Nlrp3-/- mice (background C57BL/6) during S. Typhimurium infection. Unexpectedly, neither ASC nor NLRP3 played a significant role in host defense against S. Typhimurium infection, as reflected by equal bacterial counts in WT, Asc-/- and Nlrp3-/- mice at all time points, in both the typhoid and colitis models. Proinflammatory cytokine levels (TNF-α, IL-6) and the extent of hepatic and splenic pathology did not differ between groups in the typhoid model. In the colitis model small differences were seen with regard to splenic and hepatic inflammation, although this was IL-18 independent. CONCLUSIONS: IL-18 release was reduced in Asc-/- but not Nlrp3-/- mice during S. Typhimurium infection. Despite this reduction, bacterial counts, cytokine levels and histological inflammation did not differ between wild-type and knockout mice in either model. Our results reveal a limited role for ASC and NLRP3 during in vivo S. Typhimurium infection despite its role in cytokine maturation.


Subject(s)
Apoptosis Regulatory Proteins/metabolism , Carrier Proteins/metabolism , Salmonella Infections, Animal/immunology , Salmonella typhimurium/immunology , Animals , Apoptosis Regulatory Proteins/deficiency , Biomarkers/metabolism , CARD Signaling Adaptor Proteins , Colitis/immunology , Colitis/microbiology , Colitis/pathology , Colony Count, Microbial , Cytokines/metabolism , Disease Models, Animal , Disease Susceptibility , Host-Pathogen Interactions/immunology , Inflammasomes/metabolism , Inflammation/pathology , Interleukin-18/metabolism , Intestines/microbiology , Intestines/pathology , Liver/pathology , Mice, Inbred C57BL , NLR Family, Pyrin Domain-Containing 3 Protein , Organ Specificity , Salmonella Infections, Animal/microbiology , Salmonella Infections, Animal/pathology , Typhoid Fever/immunology , Typhoid Fever/pathology
8.
Inflamm Res ; 63(11): 927-33, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25118783

ABSTRACT

OBJECTIVE AND DESIGN: To investigate the therapeutic effect of E5564 (a clinically used TLR4 inhibitor) in murine abdominal sepsis elicited by intraperitoneal infection with a highly virulent Escherichia coli in the context of concurrent antibiotic therapy. METHODS: Mice were infected with different doses (~2 × 10(4)-2 × 10(6) CFU) of E. coli O18:K1 and treated after 8 h with ceftriaxone 20 mg/kg i.p. combined with either E5564 10 mg/kg i.v. or vehicle. For survival studies this treatment was repeated every 12 h. Bacterial loads and inflammatory parameters were determined after 20 h in peritoneal lavage fluid, blood, liver and lung tissue. Plasma creatinin, AST, ALT and LDH were determined to assess organ injury. RESULTS: E5564 impaired bacterial clearance under the antibiotic regime after infection with a low dose E. coli (1.7 × 10(4) CFU) while renal function was slightly preserved. No differences were observed in bacterial load and organ damage after infection with a tenfold higher (1.7 × 10(5) E. coli) bacterial dose. While treatment with E5564 slightly attenuated inflammatory markers provoked by the sublethal doses of 104-105 E. coli under the antibiotic regime, it did not affect lethality evoked by infection with 1.7 × 106 E. coli. CONCLUSIONS: The impact of TLR4 inhibition during abdominal sepsis by virulent E. coli bacteria is only beneficial at low infection grade at cost of bactericidal activity.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Escherichia coli Infections/drug therapy , Lipid A/analogs & derivatives , Peritonitis/drug therapy , Sepsis/drug therapy , Toll-Like Receptor 4/antagonists & inhibitors , Animals , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Anti-Inflammatory Agents/pharmacology , Ascitic Fluid/microbiology , Bacterial Load , Ceftriaxone/pharmacology , Ceftriaxone/therapeutic use , Cytokines/blood , Cytokines/immunology , Escherichia coli/isolation & purification , Escherichia coli Infections/blood , Escherichia coli Infections/immunology , Escherichia coli Infections/microbiology , Female , Lipid A/pharmacology , Lipid A/therapeutic use , Liver/microbiology , Lung/microbiology , Mice, Inbred C57BL , Peritoneal Lavage , Peritonitis/blood , Peritonitis/immunology , Peritonitis/microbiology , Sepsis/blood , Sepsis/immunology , Sepsis/microbiology , Toll-Like Receptor 4/immunology
9.
J Innate Immun ; 6(4): 542-52, 2014.
Article in English | MEDLINE | ID: mdl-24556793

ABSTRACT

Streptococcus pneumoniae is a common cause of pneumonia and sepsis. Toll-like receptors (TLRs) play a pivotal role in the host defense against infection. In this study, we sought to determine the role of single immunoglobulin interleukin-1 receptor-related molecule (SIGIRR a.k.a. TIR8), a negative regulator of TLR signaling, in pneumococcal pneumonia and sepsis. Wild-type and SIGIRR-deficient (sigirr-/-) mice were infected intranasally (to induce pneumonia) or intravenously (to induce primary sepsis) with S. pneumoniae and euthanized after 6, 24, or 48 h for analyses. Additionally, survival studies were performed. sigirr-/- mice showed delayed mortality during lethal pneumococcal pneumonia. Accordingly, sigirr-/- mice displayed lower bacterial loads in lungs and less dissemination of the infection 24 h after the induction of pneumonia. SIGIRR deficiency was associated with increased interstitial and perivascular inflammation in lung tissue early after infection, with no impact on neutrophil recruitment or cytokine production. sigirr-/- mice also demonstrated reduced bacterial burdens at multiple body sites during S. pneumoniae sepsis. sigirr-/- alveolar macrophages and neutrophils exhibited an increased capacity to phagocytose viable pneumococci. These results suggest that SIGIRR impairs the antibacterial host defense during pneumonia and sepsis caused by S. pneumoniae.


Subject(s)
Lung/physiology , Macrophages/immunology , Neutrophils/immunology , Pneumonia, Bacterial/immunology , Receptors, Interleukin-1/metabolism , Sepsis/immunology , Streptococcal Infections/immunology , Streptococcus pneumoniae/immunology , Animals , Bacterial Load/genetics , Cells, Cultured , Lung/microbiology , Macrophages/microbiology , Mice , Mice, Inbred C57BL , Mice, Knockout , Neutrophils/microbiology , Phagocytosis/genetics , Receptors, Interleukin-1/genetics , Signal Transduction/genetics , Toll-Like Receptors/immunology
10.
J Infect Dis ; 206(9): 1415-23, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22904341

ABSTRACT

BACKGROUND: Pneumonia is frequently caused by gram-negative pathogens, among which Klebsiella pneumoniae prominently features. Recognition of pathogen-associated molecular patterns by Toll-like receptors (TLRs) is important for an appropriate immune response during infection. TLR signaling can proceed via 2 distinct routes that are dependent on the adaptor proteins Myeloid differentiation primary response gene (88) (MyD88) and TIR-domain-containing adaptor-inducing interferon-ß (TRIF). The aim of the study was to determine the relative contribution of MyD88 and TRIF signaling in resident and hematopoietic cells to host defense during pneumonia. METHODS: Bone marrow chimeras of MyD88 deficient/wild type and TRIF mutant/wild type mice were created and infected with K. pneumoniae via the airways. RESULTS: MyD88 in both resident and hematopoietic cells contributed to survival and antibacterial defense in late-stage infection, whereas only TRIF in hematopoietic cells was protective. On the other hand, resident MyD88 and hematopoietic TRIF contributed to distant cellular injury. Resident MyD88 was pivotal for early chemokine release and neutrophil recruitment in the bronchoalveolar space. CONCLUSIONS: MyD88- and TRIF-dependent signaling has a differential contribution to host defense in different cell types that changes from early- to late-stage gram-negative pneumonia.


Subject(s)
Adaptor Proteins, Vesicular Transport/immunology , Klebsiella Infections/immunology , Klebsiella pneumoniae/immunology , Myeloid Differentiation Factor 88/immunology , Pneumonia, Bacterial/immunology , Adaptor Proteins, Vesicular Transport/genetics , Animals , Female , Klebsiella Infections/pathology , Klebsiella pneumoniae/pathogenicity , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Myeloid Differentiation Factor 88/genetics , Pneumonia, Bacterial/pathology , Survival Analysis
11.
Mol Med ; 18: 1086-95, 2012 Sep 25.
Article in English | MEDLINE | ID: mdl-22692577

ABSTRACT

Bacterial pneumonia remains associated with high morbidity and mortality. The gram-positive pathogen Streptococcus pneumoniae is the most common cause of community-acquired pneumonia. Lipoteichoic acid (LTA) is an important proinflammatory component of the gram-positive bacterial cell wall. R-roscovitine, a purine analog, is a potent cyclin-dependent kinase (CDK)-1, -2, -5 and -7 inhibitor that has the ability to inhibit the cell cycle and to induce polymorphonuclear cell (PMN) apoptosis. We sought to investigate the effect of R-roscovitine on LTA-induced activation of cell lines with relevance for lung inflammation in vitro and on lung inflammation elicited by either LTA or viable S. pneumoniae in vivo. In vitro R-roscovitine enhanced apoptosis in PMNs and reduced tumor necrosis factor (TNF)-α and keratinocyte chemoattractant (KC) production in MH-S (alveolar macrophage) and MLE-12/MLE-15 (respiratory epithelial) cell lines. In vivo R-roscovitine treatment reduced PMN numbers in bronchoalveolar lavage fluid during LTA-induced lung inflammation; this effect was reversed by inhibiting apoptosis. Postponed treatment with R-roscovitine (24 and 72 h) diminished PMN numbers in lung tissue during gram-positive pneumonia; this step was associated with a transient increase in pulmonary bacterial loads. R-roscovitine inhibits proinflammatory responses induced by the gram-positive stimuli LTA and S. pneumoniae. R-roscovitine reduces PMN numbers in lungs upon LTA administration by enhancing apoptosis. The reduction in PMN numbers caused by R-roscovitine during S. pneumoniae pneumonia may hamper antibacterial defense.


Subject(s)
Pneumonia/drug therapy , Purines/therapeutic use , Streptococcus pneumoniae/physiology , Amino Acid Chloromethyl Ketones/pharmacology , Animals , Apoptosis/drug effects , Bronchoalveolar Lavage Fluid/cytology , Caspase 3/metabolism , Cell Line , Chemokines/metabolism , Cyclin-Dependent Kinases/metabolism , Female , Humans , Inflammation Mediators/metabolism , Leukocyte Count , Lipopolysaccharides , Mice , Mice, Inbred C57BL , Neutrophils/drug effects , Neutrophils/enzymology , Neutrophils/pathology , Pneumonia/blood , Pneumonia/chemically induced , Pneumonia/microbiology , Purines/pharmacology , Roscovitine , Streptococcus pneumoniae/drug effects , Teichoic Acids
12.
Diabetes ; 55(2): 480-6, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16443784

ABSTRACT

Hyperglycemia is associated with increased susceptibility to atherothrombotic stimuli. The glycocalyx, a layer of proteoglycans covering the endothelium, is involved in the protective capacity of the vessel wall. We therefore evaluated whether hyperglycemia affects the glycocalyx, thereby increasing vascular vulnerability. The systemic glycocalyx volume was estimated by comparing the distribution volume of a glycocalyx permeable tracer (dextran 40) with that of a glycocalyx impermeable tracer (labeled erythrocytes) in 10 healthy male subjects. Measurements were performed in random order on five occasions: two control measurements, two measurements during normoinsulinemic hyperglycemia with or without N-acetylcysteine (NAC) infusion, and one during mannitol infusion. Glycocalyx measurements were reproducible (1.7 +/- 0.2 vs. 1.7 +/- 0.3 l). Hyperglycemia reduced glycocalyx volume (to 0.8 +/- 0.2 l; P < 0.05), and NAC was able to prevent the reduction (1.4 +/- 0.2 l). Mannitol infusion had no effect on glycocalyx volume (1.6 +/- 0.1 l). Hyperglycemia resulted in endothelial dysfunction, increased plasma hyaluronan levels (from 70 +/- 6 to 112 +/- 16 ng/ml; P < 0.05) and coagulation activation (prothrombin activation fragment 1 + 2: from 0.4 +/- 0.1 to 1.1 +/- 0.2 nmol/l; d-dimer: from 0.27 +/- 0.1 to 0.55 +/- 0.2 g/l; P < 0.05). Taken together, these data indicate a potential role for glycocalyx perturbation in mediating vascular dysfunction during hyperglycemia.


Subject(s)
Blood Coagulation , Endothelial Cells/metabolism , Endothelial Cells/pathology , Glycocalyx/metabolism , Hyperglycemia/metabolism , Acetylcysteine/pharmacology , Adult , Dextrans/metabolism , Endothelial Cells/drug effects , Glucose/pharmacology , Glucose Clamp Technique , Humans , Hyperglycemia/chemically induced , Male , Mannitol/pharmacology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...